Skip to main content

CD Aluise

First name:
CD
Last name:
Aluise
Aluise, C. D., Miriyala, S., Noel, T., Sultana, R., Jungsuwadee, P., Taylor, T. J., et al. (2011). 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biology & Medicine, 50(11), 1630-8. https://doi.org/10.1016/j.freeradbiomed.2011.03.009 (Original work published 2011)
Aluise, C. D., Robinson, R. A., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI. Journal Of Alzheimer's Disease : Jad, 23(2), 257-69. https://doi.org/10.3233/JAD-2010-101083 (Original work published 2011)
Owen, J. B., Sultana, R., Aluise, C. D., Erickson, M. A., Price, T. O., Bu, G., et al. (2010). Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain. Free Radical Biology & Medicine, 49(11), 1798-803. https://doi.org/10.1016/j.freeradbiomed.2010.09.013 (Original work published 2010)
Aluise, C. D., Sultana, R., Tangpong, J., Vore, M., St Clair, D., Moscow, J. A., & Butterfield, D. A. Chemo brain (chemo fog) as a potential side effect of doxorubicin administration: role of cytokine-induced, oxidative/nitrosative stress in cognitive dysfunction. Advances In Experimental Medicine And Biology, 678, 147-56. https://doi.org/10.1007/978-1-4419-6306-2_19 (Original work published 2010)
Huang, Q., Aluise, C. D., Joshi, G., Sultana, R., St Clair, D. K., Markesbery, W. R., & Butterfield, D. A. (2010). Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. Journal Of Neuroscience Research, 88(12), 2618-29. https://doi.org/10.1002/jnr.22422
Aluise, C. D., Robinson, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M., et al. (2010). Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiology Of Disease, 39(2), 221-8. https://doi.org/10.1016/j.nbd.2010.04.011
Joshi, G., Aluise, C. D., Cole, M. P., Sultana, R., Pierce, W. M., Vore, M., et al. (2010). Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience, 166(3), 796-807. https://doi.org/10.1016/j.neuroscience.2010.01.021 (Original work published 2010)
Aluise, C. D., St Clair, D., Vore, M., & Butterfield, D. A. (2009). In vivo amelioration of adriamycin induced oxidative stress in plasma by gamma-glutamylcysteine ethyl ester (GCEE). Cancer Letters, 282(1), 25-9. https://doi.org/10.1016/j.canlet.2009.02.047 (Original work published 2009)
Aluise, C. D., Sowell, R. A., & Butterfield, D. A. (2008). Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease. Biochimica Et Biophysica Acta, 1782(10), 549-58. https://doi.org/10.1016/j.bbadis.2008.07.008